Article Versions Notes

Milczarek M, Cierpiał T, Kiełbasiński P, Małecka-Giełdowska M, Świtalska M, Wietrzyk J, Mazur M, Wiktorska K. An Organofluorine Isoselenocyanate Analogue of Sulforaphane Affects Antimetabolite 5-Fluorouracil’s Anticancer Activity: A Perspective for New Combinatory Therapy in Triple-Negative Breast Cancer. Molecules. 2023; 28(15):5808. https://doi.org/10.3390/molecules28155808

Milczarek, Małgorzata, Tomasz Cierpiał, Piotr Kiełbasiński, Milena Małecka-Giełdowska, Marta Świtalska, Joanna Wietrzyk, Maciej Mazur, and Katarzyna Wiktorska. 2023. "An Organofluorine Isoselenocyanate Analogue of Sulforaphane Affects Antimetabolite 5-Fluorouracil’s Anticancer Activity: A Perspective for New Combinatory Therapy in Triple-Negative Breast Cancer" Molecules 28, no. 15: 5808. https://doi.org/10.3390/molecules28155808

Milczarek, M., Cierpiał, T., Kiełbasiński, P., Małecka-Giełdowska, M., Świtalska, M., Wietrzyk, J., Mazur, M., & Wiktorska, K. (2023). An Organofluorine Isoselenocyanate Analogue of Sulforaphane Affects Antimetabolite 5-Fluorouracil’s Anticancer Activity: A Perspective for New Combinatory Therapy in Triple-Negative Breast Cancer. Molecules, 28(15), 5808. https://doi.org/10.3390/molecules28155808